A5092107016- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Atherosclerosis and Cardiovascular Diseases
- Cardiac Arrest and Resuscitation
- Respiratory Support and Mechanisms
- Platelet Disorders and Treatments
- Systemic Lupus Erythematosus Research
- Intensive Care Unit Cognitive Disorders
- SARS-CoV-2 detection and testing
- Long-Term Effects of COVID-19
Danderyds sjukhus
2022-2023
Karolinska Institutet
2023
The effects of high-dose inhaled nitric oxide on hypoxemia in coronavirus disease (COVID-19) acute respiratory failure are unknown.
Abstract Background Both severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viremia and nasopharyngeal viral load have been suggested to be predictors of unfavorable outcome in disease 2019 (COVID-19). This study aimed investigate whether is correlated with outcome. Methods The presence SARS-CoV-2 RNA was determined paired serum samples collected at admission from patients hospitalized for COVID-19. Standardized cycle threshold values (CT values) were used as an indicator load. An...
Studies on the antiviral effects of remdesivir have shown conflicting results. SARS-CoV-2 viraemia could identify patients in whom treatment may be particularly beneficial.To investigate and clinical outcomes viraemic patients.Viraemic hospitalized for COVID-19 with ratio arterial oxygen partial pressure to fractional inspired ≤300, symptom duration ≤10 days, estimated glomerular filtration rate ≥30 mL/min were included a cohort. The serum viral clearance load decline, 60 day mortality...
<h3>Background</h3> Recurrent thrombosis in patients with antiphospholipid syndrome (APS) is a major clinical concern and treatment challenge. Data regarding risk factors markers of recurrent APS patients, particularly during long-term follow-up, limited. <h3>Objectives</h3> We aimed to study the effect cardiovascular (CV) antibody (aPL) profiles on APS. continued explore if occurrence thrombocytopenia decline kidney function over time could be considered factors. <h3>Methods</h3> This...